Hjem › Akut myelogen leukemi › New Jersey › Clifton
Kliniske studier for Akut myelogen leukemi i Clifton, NJ
12 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Clifton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Hackensack University Medical Center, Hackensack · 7 mi unna
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RekruttererFase 2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi unna
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- Hackensack University Medical Center, HMH, Hackensack · 7 mi unna
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruttererFase 2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruttererFase 2/3
- John Theurer Cancer Center / Hackensack University, Hackensack · 7 mi unna
Phase IB/II of CPX-351 for Relapse Prevention in AML
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Clifton
- Ikke-småcellet lungekreft24 studier
- Kreft (alle typer)15 studier
- Multipelt myelom14 studier
- Metastatisk kreft12 studier
- Brystkreft12 studier
- Prostatakreft12 studier
- Eggstokkreft11 studier
- Lungekreft10 studier
- Kolorektal kreft8 studier
- Plateepitelcancer i hode og hals8 studier
- Endometriekreft8 studier
- Hjertesvikt8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.